Press releases
Access archived Guidant press releases
Access archived BTG press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Mar 24, 2005
(March 24, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that a jury in Delaware issued a verdict in a retrial of patent litigation between Boston Scientific and Johnson &...
-
Mar 15, 2005
(March 15, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Quincy Distribution Center as a...
-
Mar 11, 2005
(March 11, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that its Maple Grove, Minnesota manufacturing facility has received the 2005 Shingo Prize for Excellence in...
-
Mar 10, 2005
(March 10, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in SG Cowen & Co.'s 25th Annual Health Care Conference, which is being held March 14 - 17 at the Marriott...
-
Mar 9, 2005
(March 9, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has completed enrollment in its three-year ENTERYX® Procedure clinical trial. The post-approval clinical trial...
-
Mar 6, 2005
and Orlando, FL (March 6, 2005) -- Boston Scientific Corporation (NYSE: BSX) today welcomed the results of Johnson & Johnson's REALITY clinical trial, which reaffirmed the safety and efficacy of...
-
Mar 6, 2005
and Orlando, FL (March 6, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced nine-month results from its TAXUS V clinical trial, confirming the safety and efficacy of the TAXUS®...
-
Mar 4, 2005
(March 4, 2005) -- Boston Scientific Corporation (NYSE:BSX) today announced that it has completed its acquisition of Advanced Stent Technologies, Inc. (AST) of Pleasanton, California, for an...
-
Mar 3, 2005
(March 3, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events at the American College of Cardiology annual scientific session, which runs...
-
Feb 23, 2005
(February 23, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the start of enrollment in the world's largest drug-eluting stent registry. The TAXUS OLYMPIC registry plans to...
-
Feb 22, 2005
(February 22, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has completed enrollment in its ATLAS clinical trial. ATLAS is the first trial using Boston Scientific's...
-
Feb 16, 2005
(February 16, 2005) -- Boston Scientific Corporation (NYSE: BSX) today welcomed an announcement by the Interventional Procedures Advisory Committee (IPAC) of the United Kingdom's National...
-
Feb 2, 2005
(February 2, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2005 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference, which is...
-
Feb 1, 2005
and New York, NY (February 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) today provided financial guidance for 2005 and announced financial goals for 2006 and 2007 at a meeting with...
-
Jan 31, 2005
(January 31, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has completed the initial launch of its TAXUS® Liberté™ paclitaxel-eluting coronary stent system. On...
-
Jan 27, 2005
(January 27, 2005) -- Boston Scientific Corporation (NYSE: BSX) will simultaneously webcast the analyst meeting it is hosting on Tuesday, February 1. The meeting is scheduled to begin at 9:00 a.m....
-
Jan 20, 2005
(January 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2005 Piper Jaffray Health Care Conference, which is being held January 25-27 in New York City....
-
Jan 19, 2005
(January 19, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the implantation of its millionth TAXUS® Express2™ paclitaxel-eluting coronary stent system, marking a major...
-
Jan 17, 2005
(January 17, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has launched its TAXUS™ Liberté™ paclitaxel-eluting coronary stent system in 18 countries. The TAXUS...
-
Jan 10, 2005
and San Francisco, CA (January 10, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced preliminary, unaudited sales results for the fourth quarter and for the year ended December...
-
Jan 6, 2005
(January 6, 2005)-- Boston Scientific Corporation (NYSE: BSX) announced today that the U.S. District Court in Delaware has granted summary judgment of non-infringement in favor of Boston...
-
Jan 4, 2005
(January 4, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 23rd Annual JPMorgan Healthcare Conference, which is being held January 10-13 in San Francisco....
-
Dec 31, 2004
and New York, NY (February 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for the fourth quarter and for the year ended December 31, 2004 at a meeting with...
-
Dec 30, 2004
(December 30, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that it is donating $100,000 to the Red Cross for tsunami relief. The money is being directed to the Red Cross'...
-
Dec 20, 2004
(December 20, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced an expansion of its management structure designed to position the Company for continued growth and success. The...
-
Dec 16, 2004
(December 16, 2004) -- Boston Scientific Corporation (NYSE:BSX) today announced that it has entered into a definitive agreement to acquire Advanced Stent Technologies, Inc. (AST) of Pleasanton,...
-
Dec 2, 2004
(December 2, 2004) -- Boston Scientific Corporation (NYSE: BSX) today commented on a ruling by the U.S. District Court for the Southern District of New York on preliminary motions in a breach of...
-
Nov 29, 2004
(November 29, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that its Intravascular Ultrasound (IVUS) procedures have been recognized for payment under a new Medicare...
-
Nov 24, 2004
(November 24, 2004) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Lazard Frères First Annual Life Sciences Conference, which will take place November 30 and...
-
Nov 23, 2004
(November 23, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that it had exercised its right under an existing licensing agreement with Angiotech Pharmaceuticals, Inc. (NASDAQ:...
-
Nov 22, 2004
(November 22, 2004) -- Boston Scientific Corporation (NYSE: BSX) today welcomed an announcement by the French government that it has added new categories of "high-risk" patients to the...
-
Nov 18, 2004
(November 18, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced the completion of its public offering of $250 million aggregate principal amount of its 4.250 percent senior notes...
-
Nov 16, 2004
(November 16, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has made an equity investment in -- and secured an exclusive option to purchase -- REVA Medical, Inc., a...
-
Nov 15, 2004
(November 15, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today the launch of a public offering of two series of its senior notes under the Company's existing shelf registration...
-
Nov 12, 2004
(November 12, 2004) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Credit Suisse First Boston Healthcare Conference 2004, which is being held November 17-19 in...
-
Nov 8, 2004Boston Scientific Announces Resumption of Distribution of Advanced Bionics Cochlear Auditory Implant
(November 8, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that its subsidiary, Advanced Bionics Corporation of Valencia, California, is resuming worldwide distribution of its...
-
Nov 5, 2004
(November 5, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that its TAXUS™ Express2™ paclitaxel-eluting coronary stent system will be the subject of 15 presentations at...
-
Nov 4, 2004
(November 4, 2004) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the CIBC World Markets Fifteenth Annual Healthcare Conference, which is being held November 8-10 in...
-
Nov 2, 2004
and Orlando, FL (November 2, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced interim results from a 200-patient clinical trial to evaluate the effectiveness, safety and...
-
Nov 2, 2004
and Orlando, FL (November 2, 2004)-- Boston Scientific Corporation (NYSE: BSX) today announced results supporting the efficacy of the Enteryx Procedure in relieving the symptoms of...
-
Nov 2, 2004
and Orlando, FL (November 2, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced two-year follow-up data from its ongoing Enteryx Procedure clinical trial for the treatment of...
-
Nov 1, 2004
(November 1, 2004) -- Boston Scientific Corporation (NYSE: BSX) today welcomed an announcement by the Interventional Procedures Advisory Committee (IPAC) of the National Institute for Clinical...
-
Oct 28, 2004
(October 28, 2004) -- Boston Scientific Corporation (NYSE:BSX) today announced that it has launched a full line of mid-urethral sling products for the treatment of female stress urinary...
-
Oct 27, 2004
(October 27, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced the start of enrollment in the ARRIVE 2 registry program, which plans to enroll 5,000 patients at approximately 60...
-
Oct 26, 2004
(October 26, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that its Board of Directors has authorized the repurchase of up to 50 million shares of the Company's common stock...
-
Oct 19, 2004
(October 19, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for its third quarter ended September 30, 2004. Highlights: Net sales of $1.482 billion, an...
-
Oct 13, 2004
(October 13, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its new coronary...
-
Oct 6, 2004
(October 6, 2004) -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the third quarter ended September 30, 2004 on Tuesday, October 19,...
-
Oct 1, 2004
and Washington, D.C. (October 1, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced data supporting safety from three post-market registries associated with its TAXUS™...
-
Oct 1, 2004
and Washington, D.C. (October 1, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced 30-day safety data from its TAXUS V clinical trial. The trial is assessing the slow-release...